About 2,753 results

ALLMedicine™ Opioid Abuse Center

Research & Reviews  722 results

Buprenorphine/Naloxone Toxicity

May 12th, 2022 - Practice Essentials Buprenorphine, a schedule III partial mu receptor agonist, is approved by the US Food and Drug Administration (FDA) for the treatment of opioid dependence and pain. Buprenoprhine alone (Buprenex) is available in injectable form...

Stigma by Association: To what Extent is the Attitude Toward Naloxone Affected by the S...
Journal of Pharmacy Practice; Adeosun SO

May 5th, 2022 - The United States opioid epidemic is fueled by illicit opioid abuse and prescription opioid misuse and abuse. Consequently, cases of opioid use disorder (OUD, opioid addiction), opioid overdose, and related deaths have increased since the year 200...

Opioid and Naloxone Prescribing Following Insertion of Prompts in the Electronic Health...
JAMA Network Open; Duan L, Lee MS et. al.

May 3rd, 2022 - Opioid addiction or dependency is a serious crisis in the US that affects public health as well as social and economic welfare. The State of California passed Assembly Bill (AB) 2760 in 2018 that mandates the coprescription of naloxone and opioids...

Regulation of clock and clock-controlled genes during morphine reward and reinforcement...
Journal of Psychopharmacology (Oxford, England); Custodio RJP, Kim M et. al.

Apr 30th, 2022 - Morphine abuse is a devastating disorder that affects millions of people worldwide, and literature evidence indicates a relationship between opioid abuse and the circadian clock. We explored morphine reward and reinforcement using mouse models wit...

Opioid abuse risk among student pharmacists.
Journal of Opioid Management; Patel JJ, Volino LR et. al.

Apr 28th, 2022 - To benchmark opioid abuse risk among student pharmacists attending three northeast pharmacy schools utilizing the opioid risk tool (ORT). A cross-sectional, anonymous risk assessment questionnaire. Three pharmacy schools in the northeast United St...

see more →

Guidelines  3 results

Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: A...
Pain Physician; Manchikanti L, Kaye AM et. al.

Feb 23rd, 2017 - Opioid use, abuse, and adverse consequences, including death, have escalated at an alarming rate since the 1990s. In an attempt to control opioid abuse, numerous regulations and guidelines for responsible opioid prescribing have been developed by ...

American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible o...
Pain Physician; Manchikanti L, Abdi S et. al.

Jul 20th, 2012 - Part 2 of the guidelines on responsible opioid prescribing provides the following recommendations for initiating and maintaining chronic opioid therapy of 90 days or longer. 1. A) Comprehensive assessment and documentation is recommended before in...

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.
The Journal of Pain; Chou R, Fanciullo GJ et. al.

Feb 4th, 2009 - Use of chronic opioid therapy for chronic noncancer pain has increased substantially. The American Pain Society and the American Academy of Pain Medicine commissioned a systematic review of the evidence on chronic opioid therapy for chronic noncan...

see more →

Drugs  11 results see all →

Clinicaltrials.gov  28 results

Combined Cryotherapy With Compression Versus Cryotherapy Alone After Orthopaedic Surgery

Apr 11th, 2022 - Opioids are most commonly administered for the treatment of pain and are among the most prescribed drugs in the United States (US). Between 2003 and 2011, opioid prescriptions increased from 149 million to 238 million [3,5,7,11]. In 2004, while co...

Determinants and Effects in the Use of NOHARM Pain Management

Mar 31st, 2022 - Aim 1: Explore differences in patient engagement with the NOHARM intervention, use of non-pharm modalities, and clinical outcomes by key patient demographics, including surgical procedure type, gender, and opioid abuse risk. This aim will provide ...

Encouraging Abstinence Behavior in a Drug Epidemic

Mar 4th, 2022 - Over the past decade, the annual number of drug-related deaths more than doubled in the United States (Swensen, 2015). In particular, over the 2001-2013 period, overdose deaths involving prescription pain relievers tripled while those involving he...

Opiate Sparing Protocol Randomized Controlled Trial in Open Distal Radius Fracture Repair

Feb 21st, 2022 - Recently, the opioid epidemic has been the center of focus for healthcare providers and governmental agencies due to rising rates of opioid abuse, opioid-related fatalities, and overall economic burden of treating the opioid epidemic. The prescrib...

Reducing the Abuse of Opioids in Drug Users

Feb 15th, 2022 - The consequences of prescription opioid abuse are serious and the number of deaths from unintended overdose have quadrupled over the last 15+ years. Opioid analgesics remain among the most commonly abused class of substances in the United States. ...

see more →

News  336 results

Long-term Opioid Use a Risk Factor for Cancer

Apr 12th, 2022 - The study covered in this summary was published in papers.ssrn.com as a preprint and has not yet been peer-reviewed. Key Takeaways Patients with a history of long-term opioid use for chronic pain have an elevated risk for cancer, according to this...

Purpura Fulminans in an Asplenic Intravenous Drug User
Emily S. Nyers, MD, Rachael H. Kappius, MD et. al.

Nov 18th, 2021 - To the Editor: A 56-year-old man with a history of opioid abuse and splenectomy decades prior due to a motor vehicle accident was brought to an outside emergency department with confusion, slurred speech, and difficulty breathing. Over the next fe.

Oklahoma Court Overturns $465M Opioid Ruling Against J&J

Nov 9th, 2021 - OKLAHOMA CITY (AP) — The Oklahoma Supreme Court on Tuesday overturned a $465 million opioid ruling against drugmaker Johnson & Johnson, finding that a lower court wrongly interpreted the state's public nuisance law in the first case of its kind in...

Trial Against Pharmacy Chains' Opioid Sales Set to Begin

Oct 4th, 2021 - CLEVELAND (AP) — Opening statements are scheduled for Monday afternoon in Cleveland in a federal court trial to determine whether retail pharmacy chains created a public nuisance in how they dispensed addictive painkillers in two Ohio counties whe...

US States Rush to Meet Deadline to Join $26 Billion Opioid Settlement

Aug 20th, 2021 - (Reuters) - U.S. states are racing to meet a deadline to commit to a $26 billion opioid settlement with three drug distributors and the drugmaker Johnson & Johnson, as some grapple with local resistance and concerns the amount isn't big enough to ...

see more →

Patient Education  1 results see all →